Chan J L, Stoyneva V, Kelesidis T, Raciti P, Mantzoros C S
Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Diabetologia. 2006 Jan;49(1):169-73. doi: 10.1007/s00125-005-0041-2. Epub 2005 Dec 9.
AIMS/HYPOTHESIS: Peptide YY (PYY) is a gut-derived hormone that has been shown to reduce short-term food intake in animals and humans. It has been proposed that deficiency of PYY contributes to obesity in humans. However, the physiology of PYY regulation by factors such as caloric restriction, or by other molecules important in energy homeostasis, e.g. leptin, remains to be fully elucidated.
We evaluated the effect on PYY levels of: (1) caloric ingestion (a mixed meal) in five healthy normal-weight subjects; (2) fasting for 2 or 3 days in eight lean men and seven lean women respectively; and (3) recombinant human leptin administration at physiological replacement and pharmacological doses.
PYY levels increased 50% after a mixed meal (p=0.01), and short-term complete fasting for 2 or 3 days decreased leptin and PYY levels to 20-30% and 40-60% of baseline, respectively (both p<0.05). However, recombinant human leptin administration at physiological doses to restore the fasting-induced decrease of leptin levels and at pharmacological doses over the short term had no effect on PYY levels.
CONCLUSIONS/INTERPRETATION: PYY increases after meal ingestion and decreases after fasting in a manner consistent with a meal-related signal of energy homeostasis. Importantly, circulating levels of this gut-secreted molecule are independent of regulation by leptin over the short term. These findings contribute towards our understanding of the homeostatic systems that regulate appetite in humans, including the possible redundancy of gastrointestinally secreted and adipocyte-secreted signals. This may be of importance for the future development of medications to treat obesity.
目的/假设:肽YY(PYY)是一种源自肠道的激素,已被证明可减少动物和人类的短期食物摄入量。有人提出,PYY缺乏会导致人类肥胖。然而,热量限制等因素或能量稳态中其他重要分子(如瘦素)对PYY调节的生理学机制仍有待充分阐明。
我们评估了以下因素对PYY水平的影响:(1)五名健康正常体重受试者摄入热量(一顿混合餐);(2)分别对八名瘦男性和七名瘦女性进行2天或3天的禁食;(3)以生理替代剂量和药理剂量给予重组人瘦素。
混合餐后PYY水平升高50%(p = 0.01),短期完全禁食2天或3天分别使瘦素和PYY水平降至基线的20 - 30%和40 - 60%(均p < 0.05)。然而,以生理剂量给予重组人瘦素以恢复禁食诱导的瘦素水平下降,以及短期内以药理剂量给予,对PYY水平均无影响。
结论/解读:PYY在进食后升高,禁食后降低,其方式与能量稳态的进食相关信号一致。重要的是,这种肠道分泌分子的循环水平在短期内不受瘦素调节。这些发现有助于我们理解调节人类食欲的稳态系统,包括胃肠道分泌信号和脂肪细胞分泌信号可能存在的冗余。这可能对未来治疗肥胖药物的开发具有重要意义。